by Greg Crowhurst, Stonebird
With severe ME, everything is cut off from possibility
Posted in News
Tagged Greg Crowhurst, severe ME, Stonebird
Comments Off on With severe ME, everything is cut off from possibility
Stonebird – the lived experience of severe METhe frail teenager set to spend all of her summer holidays in her bedroom
Wales online blog post: The frail teenager set to spend all of her summer holidays in her bedroom, by Mark Smith, 6 August 2019
Lola Brandrick, 13, from Swansea, is crippled by pain and is constantly exhausted
While all her school mates are out enjoying their summer holidays, poor Lola Brandrick can only dream of joining them.
The 13-year-old is confined to her bed, constantly exhausted and crippled by widespread pain due to a condition which continues to puzzle many doctors.
Even the smallest of tasks can have a devastating impact on the teenager’s energy levels for days, weeks or even months afterwards.
But ever since she was diagnosed with myalgic encephalomyelitis (ME) at the age of seven her family have fought to get her the care and support she desperately needs.
“Having to battle all the time just to be believed has been heartbreaking,” said her mum Victoria Lewis, 45, a fitness instructor and mum-of-two from Swansea.
Posted in News
Tagged Lola Bandrick, Mark Smith, severe ME, Swansea, Victoria Lewis, Wales online
Comments Off on The frail teenager set to spend all of her summer holidays in her bedroom
Severe ME day- 8 August 2019
Severe ME Day – 8th of August 2019
A day to remember everyone who is suffering or who has ever suffered from severe and very severe Myalgic Encephalomyelitis.
The 25% Group offers support for severe ME.
They have published a 2 page info sheet: How can I help someone with severe ME?
Excerpts:
Even severe illness may not be instantly apparent – for example your friend/relative may be able to walk to the toilet, yet be too ill to go out in a wheelchair, watch TV or even sit up in bed for more than a few minutes.
They may spend most of their energy on something as basic as eating. They may look remarkably well for half an hour or an hour, but then spend the rest of the day in pain in a darkened room.
Flare up of symptoms after activity or stimuli is a key feature of the illness. The activity may be tiny by healthy standards and stimuli things you probably don’t even notice (such as light, movement, or background noise).
Here are a few ways to help: shut doors (to reduce noise), use headphones if watching TV nearby, be aware that talking uses energy – ask your friend/relative how long the conversation needs to be and try to stick to that. If they seem particularly energetic, ironically this may be a sign that they are doing too much (and running on adrenaline!) – ask if they need a rest.
Stonebird: the lived experience of severe ME – a website with information and help for and about people with severe ME, such as Severe ME: notes for carers
Posted in News
Tagged 25% ME Group, severe me day, Stonebird
Comments Off on Severe ME day- 8 August 2019
Metabolic features of Gulf War illness [similarities & differences to CFS]
Metabolic features of Gulf War illness, by Robert K Naviaux, Jane C Naviaux, Kefeng Li, Lin Wang, Jonathan M Monk, A Taylor Bright, Hayley J Koslik, Janis B Ritchie, Beatrice A Golomb in PLoS ONE 14(7): e0219531 [Published: July 26, 2019] https://doi.org/10.1371/journal.pone.0219531
Research abstract:
Background
More than 230,000 veterans—about 1/3 of US personnel deployed in the 1990–1991 Persian Gulf War—developed chronic, multi-symptom health problems now called “Gulf War illness” (GWI), for which mechanisms and objective diagnostic signatures continue to be sought.
Methods
Targeted, broad-spectrum serum metabolomics was used to gain insights into the biology of GWI. 40 male participants, included 20 veterans who met both Kansas and CDC diagnostic criteria for GWI and 20 nonveteran controls without similar symptoms that were 1:1 matched to GWI cases by age, sex, and ethnicity. Serum samples were collected and archived at -80° C prior to testing. 358 metabolites from 46 biochemical pathways were measured by hydrophilic interaction liquid chromatography and tandem mass spectrometry.
Metabolic similarities & differences between Gulf War illness & CFS
Results
Veterans with GWI, compared to healthy controls, had abnormalities in 8 of 46 biochemical pathways interrogated. Lipid abnormalities accounted for 78% of the metabolic impact. Fifteen ceramides and sphingomyelins, and four phosphatidylcholine lipids were increased.
Five of the 8 pathways were shared with the previously reported metabolic phenotype of males with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). However, 4 of the 5 shared pathways were regulated in opposite directions; key pathways that were up-regulated in GWI were down-regulated in ME/CFS. The single pathway regulated in the same direction was purines, which were decreased.
Conclusions
Our data show that despite heterogeneous exposure histories, a metabolic phenotype of GWI was clearly distinguished from controls. Metabolomic differences between GWI and ME/CFS show that common clinical symptoms like fatigue can have different chemical mechanisms and different diagnostic implications. Larger studies will be needed to validate these findings.
Posted in News
Tagged A Taylor Bright, Beatrice A Golomb, biochemical pathways, Dr Robert Naviaux, Gulf War Illness, Hayley J Koslik, Jane C Naviaux, Janis B Ritchie, Jonathan M Monk, Kefeng Li, Lin Wang, metabolic pathways, metabolic phentoype, Robert K Naviaux
Comments Off on Metabolic features of Gulf War illness [similarities & differences to CFS]
CFS – an illness without disease?
CFS – an illness without disease?
In a recent paper psychologist Prof Michael Sharpe and sociologist Monica Greco discuss CFS as an ‘illness without disease’ in comparison to cancer, a known disease, and argued that, while illness-focused treatments like CBT and GET can ameliorate the symptom of fatigue, there is also a need to address the paradoxical predicament of illness-without-disease that patients find themselves in.
Chronic fatigue syndrome and an illness-focused approach to care: Controversy, morality and paradox, by Michael Sharpe and Monica Greco in Medical humanities 2019; 45: 183-187.
More science and less philosophy needed, by Susanna Agardy, Retired due to ME/CFS
At the heart of Sharpe and Greco’s article lies the complaint that while cancer patients accept CBT/GET treatments for their fatigue, ME/CFS patients reject these treatments. Of course they do! ME/CFS patients have a different disease, the main feature of which makes them unable to increase exertion.
The article contains several omissions and misinterpretations…
The argument provides a rationale for a science-denying approach to ME/CFS and endangers patient welfare. It is a departure from the previous model of more directly trying to correct patients’ ‘dysfunctional thinking’ and consequent ‘deconditioning’. This version of the Emperor’s New Clothes is also unacceptable…
Science, physiology and clarification of misleading terms, by Adi C Wood, Scientist ME
The view held by these authors that chronic fatigue syndrome is an illness without disease is at odds with the findings of the National Academy of Science, physiological and bio-medical researchers worldwide…
Sharp & Greco want us to abandon science, by Michael N Dyson, Computer Technician
Sharp & Greco state: “This new approach assumes that the reality of illness has a complex and indeterminate character”.
If by this they mean that the cause of any given illness cannot in principle be determined – as I suspect they are – then it is clear that they are abandoning the scientific enterprise. We ask Sharp and Greco: do they say illness is an effect? If they do then ipso facto they concede it has a cause or causes, and it is the task of science, in the broadest sense, to elucidate those causes…
Posted in News
Tagged Adi C Wood, disease, illness-focussed approach to care, Michael N Dyson, Monica Greco, Prof Michael Sharpe, Susanna Agardy
Comments Off on CFS – an illness without disease?
MAGENTA trial comment: ‘Targeting activity levels in ME/CFS
Michiel Tack queries some conclusions of the recently published MAGENTA trial paper.
Physical activity patterns among children and adolescents with mild-to-moderate chronic fatigue syndrome/myalgic encephalomyelitis, by Emma Solomon-Moore, Russell Jago, Lucy Beasant, Amberly Brigden, Esther Crawley in BMJ Paediatrics Open Volume 3, Issue 1, 2019
The study concludes:
- Children and adolescents with chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) are less active than the general child population, but not all are inactive. 9.4% of participants met physical activity recommendations.
- Compared with being ‘inactive’, ‘active’ children reported greater physical function but increased anxiety, while ‘lightly’ active children reported greater physical function and reduced fatigue.
- Paediatricians need to recognise that physical activity varies between patients with CFS/ME when they recommend treatment.
Comment: Targeting activity levels in ME/CFS, by Michiel Tack in BMJ Paediatrics Open [Published on: 15 July 2019]
Contrary to what is claimed by Solomon-Moore et al., [1] the study by Van der Werf et al., (reference 17) [2] found little evidence of a boom and bust activity pattern in adult patients with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). The Dutch researchers measured physical activity using actimeters worn for 12 consecutive days. There was no significant difference in day-to-day fluctuations in physical activity between ME/CFS patients and controls. The peak amplitude and peak duration of physical activity were larger in controls than in ME/CFS patients while the latter had longer rest duration after an activity peak. Another actimeter study [3] found no supporting evidence of a more fluctuating activity pattern in patients with ME/CFS compared to controls, during the day, nor during consecutive days.
Now, Solomon-Moore et al. report that in children and adolescents with ME/CFS, no fluctuating active or boom-bust physical activity pattern could be identified.
It would be helpful if the authors could clarify how the actimeter data impacted the treatments in the MAGENTA trial. According to the trial protocol [4], one of the interventions aimed to “convert a boom–bust pattern of activity (lots 1 day and little the next) to a baseline with the same daily amount”. Was this aspect removed from the intervention now that participants showed little indication of a boom–bust activity pattern? Or were young ME/CFS patients instructed to correct illness behavior they did not display when tested objectively?
Solomon-Moore et al., [1] also report that 9.4% of participants achieved government recommended levels of physical activity for children and adolescents, namely a minimum of 60 minutes of moderate to vigorous physical activity per day. This is of interest given that approximately half of healthy children and adolescents do not reach this target. [1] These results indicate that activity patterns are unlikely to be a key factor in perpetuating ME/CFS symptoms, at least for this subgroup. Nonetheless, one of the interventions in the MAGENTA trial aims for a gradual increase in physical activity by prescribing exercise targets. Were ME/CFS patients who already met government health recommendations for physical activity also instructed to increase their amount of exercise by 10-20% a week or were they exempted?
I look forward to reading the authors’ response to these questions.
References
[1] Solomon-Moore E, Jago R, Beasant L, Brigden A, Crawley E. Physical activity patterns among children and adolescents with mild-to-moderate chronic fatigue syndrome/myalgic encephalomyelitis. BMJ Paediatr Open. 2019 May 2;3(1):e000425. 2019.
[2] van der Werf SP, Prins JB, Vercoulen JH, et al. Identifying physical activity patterns in chronic fatigue syndrome using actigraphic assessment. J Psychosom Res 2000;49:373–9.
[3] Meeus M, van Eupen I, van Baarle E, De Boeck V, Luyckx A, Kos D, et al. Symptom fluctuations and daily physical activity in patients with chronic fatigue syndrome: a case-control study. Arch Phys Med Rehabil. 2011 Nov;92(11):1820-6.
[4] Brigden A, Beasant L, Hollingworth W, et al. Managed activity graded exercise iN teenagers and pre-Adolescents (magenta) feasibility randomised controlled trial: study protocol. BMJ Open 2016;6:e011255.
Posted in News
Tagged adolescents, Amberly Brigden, boom and bust behaviour, children, Dr Esther Crawley, Emma Solomon-Moore, Lucy Beasant, MAGENTA trial, Michiel Tack, physical activity, Russell Jago, teenagers
Comments Off on MAGENTA trial comment: ‘Targeting activity levels in ME/CFS
Acceptance, fatigue severity & self-reported physical activity in individuals with CFS/ME
Acceptance, fatigue severity and self-reported physical activity in individuals with chronic fatigue syndrome/myalgic encephalomyelitis, by Neil Chapman, Suzanne Broadbent, Rosanne Coutts in Fatigue: Biomedicine, Health & Behavior, Volume 7, 2019, Issue 2, Pages 102-115 [Preprint June 28, 2019]
Abstract:
Background
Acceptance is a coping strategy associated with chronic pain management, but its effectiveness is unclear for Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME).
Objective
The aim of the study was to investigate the relationship between acceptance, fatigue severity, pain and self-reported physical activity in individuals with CFS/ME.
Method
Ten females and seven males diagnosed with CFS/ME (51.9 p/m 8.8 years), and gender, age-matched sedentary controls, completed self-reported measures of acceptance, fatigue severity and physical activity. Acceptance was measured using the Chronic Pain Acceptance Questionnaire and Acceptance and Action Questionnaire-II. Fatigue was assessed with the Fatigue Severity Scale, and Physical Activity using the International Physical Activity Questionnaire – Short Form. Self-reported physical activity was calculated using categorical and continuous measures (MET-minutes).
Result
CFS/ME and control groups were compared using Independent t-tests and Spearman’s Rho correlations. The CFS/ME group reported significantly greater fatigue severity and psychological inflexibility, and lower pain willingness and time spent sitting than controls. However, no between-group differences for activity engagement or physical activity. The CFS/ME group showed a negative relationship between pain willingness and psychological inflexibility, and a positive relationship between walking time and the time since symptom onset, and time since diagnosis.
Conclusion
Despite reporting greater fatigue and less acceptance of their illness, CFS/ME patients had comparable levels of physical activity to controls, possibly due to pacing their activity to avoid symptom exacerbation. CFS/ME patients with an older diagnosis walked further than the newly diagnosed, suggesting the development of better coping skills and management strategies over time.
Posted in News
Tagged acceptance, Neil Chapman, physical activity, psychological flexibility, Rosanne Coutts, Suzanne Broadbent
Comments Off on Acceptance, fatigue severity & self-reported physical activity in individuals with CFS/ME
Advances in understanding the pathophysiology of CFS
Advances in understanding the pathophysiology of Chronic Fatigue Syndrome, by Anthony L Komaroff in JAMA [Preprint July 5, 2019]
Viewpoint extracts:
When does an illness become a disease? When the underlying biological abnormalities that cause the symptoms and signs of the illness are clarified.
The illness now called myalgic encephalomyelitis/ chronic fatigue syndrome (ME/CFS) was first described in the mid-1980s. At that time, nothing was known about its underlying biology. Indeed, because many
standard laboratory test results were normal, some clinicians explained to patients that ‘there is nothing wrong.’ There was, of course, an alternative explanation: the standard laboratory tests might not have been the right tests to identify the underlying abnormalities.
Over the past 35 years, thousands of studies from laboratories in many countries have documented underlying biological abnormalities involving many organ systems in patients with ME/CFS, compared with healthy controls: in short, there is something wrong. Moreover, most of the abnormalities are not detected by standard laboratory tests. In 2015, the Institute of Medicine of the National Academy of Sciences concluded that ME/CFS ‘is a serious, chronic, complex systemic disease that often can profoundly affect the lives of patients,’ affects up to an estimated 2.5 million people in the United States, and generates direct and indirect expenses of approximately $17 billion to $24 billion annually…
A 2-day conference at the NIH in April 2019 highlighted recent progress. New research was presented that both reinforced and expanded on previous reports. Equally important, several plausible models were proposed that could explain many of the abnormalities that have been described.
The Central and Autonomic Nervous System
Metabolic Changes
Immunologic Changes
Provocation Studies
Potential Unifying Models
Conclusions
A great deal more is known today than 35 years ago about the underlying biology of ME/CFS. It is clear that many biological measurements clearly distinguish patients with ME/CFS from healthy control individuals.
At the same time, some areas of ME/CFS research remain a challenge, and research has not yet given practicing physicians 2 important tools. First, there are as yet no US Food and Drug Administration-approved treatments. Second, although various biological measurements distinguish patients with ME/CFS from healthy controls, none yet have demonstrated the high sensitivity and specificity required for a good diagnostic test. However, 1 small study (20 cases and 20 controls) described at the NIH conference (and recently published9) reported perfect sensitivity; the specificity of the test in individuals with other fatiguing illnesses remains to be shown.
With growing international interest in the illness, and increased research support from the NIH, the day is coming when physicians will be able to explain to patients not only that there is something wrong but also that advances in understanding the pathophysiology have led to effective therapy.
Posted in News
Tagged autonomic nervous system, Central Nervous System, etiopathology, illness models, immunological dysfunction, post-exertional deterioration, Prof Anthony Komaroff, provocation studies
Comments Off on Advances in understanding the pathophysiology of CFS
Pathological mechanisms underlying ME/CFS
Pathological mechanisms underlying Myalgic Encephalomyelitis/Chronic Fatigue Syndrome, by Daniel Missailidis, Sarah Annesley, Paul Fisher in Preprints [Published online: 16 July 2019] doi: 10.20944/preprints201907.0196.v1
Review abstract
The underlying molecular basis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is not well understood. Characterized by chronic, unexplained fatigue, a disabling payback following exertion (“post-exertional malaise”) and variably presenting, multi-system symptoms, ME/CFS is a complex disease which demands concerted biomedical investigation from disparate fields of expertise. ME/CFS research and patient treatment have been challenged by the lack of diagnostic biomarkers and finding these is a prominent direction of current work. Despite these challenges, modern research demonstrates a tangible biomedical basis for the disorder across many body systems.
This evidence is largely comprised of disturbances to immunological and inflammatory pathways, autonomic and neurologic systems, abnormalities in muscle and mitochondrial function, shifts in metabolism, and gut physiology or gut microbiome disturbances. It is possible that these threads are together entangled as parts of an underlying molecular pathology reflecting a far-reaching homeostatic shift affecting each of these systems.
Due to the variability of non-overlapping symptom presentation or precipitating events such as infection or other bodily stresses, the initiation of body-wide pathological cascades with similar outcomes stemming from different causes may be implicated in the condition.
Patient stratification to account for this heterogeneity is therefore one important consideration during exploration of potential diagnostic developments.
Conclusion
ME/CFS is a heterogeneous condition that may encompass scenarios where uncertain, and possibly varying, underlying insults trigger body-wide molecular and cellular perturbations perpetuated by alternative, stable homeostatic states. Diagnostic advancement and the development of tools which objectively and accurately phenotype patients is therefore paramount for the development of mechanistic insight and effective therapeutics.
It is likely that the inflammation and immune dysfunction classically studied in ME/CFS are entangled with dysfunctional energetics, gut health, or autonomic and adrenal dysregulation. The evidence for metabolic and mitochondrial dysfunction indicates inefficient respiration, impaired provision of TCA cycle substrate, and metabolic shifts towards the utilization of alternative metabolites.
Immune effector cell dysfunction, chronic inflammation, defective signalling and elevated oxidative stress may interact with not only the dysfunctional energetics but also with abnormal gut physiology and microbiota composition. These effects on the gut may also tie back to mitochondrial function and vice versa.
The reciprocal interactions between these affected systems and the varied clinical presentation of relevant symptoms between individuals make it difficult to postulate cause-effect relationships with confidence. Furthermore, while disturbances to this range of interconnected systems across the body have been demonstrated, in some cases concurrently, this body of research has historically relied upon correlations, which creates the urgent need for research utilising direct experimental investigation of cause-effect relationships.
Posted in News
Tagged Daniel Missailidis, diagnosis, Gut microbiota research, immune system, inflammation, metabolism, mitochondria, Paul Fisher, Sarah Annesley, signaling
Comments Off on Pathological mechanisms underlying ME/CFS
